The rapid global adoption of legal cannabis legislation has accelerated the need to secure and truly validate cannabis supply chains from seed-to-sale.
Abattis Bioceuticals has announced the successful completion of experiments utilizing column chromatography for cannabinoid extraction.
This announcement was included in the approval and release of edits to Bill C-45 which also outlined a deadline stating that edibles will be available to the public, alongside the marijuana adult use legalization, set to launch in 2018.
The partnership will utilize Steep Hill's expertise in analytical testing to customize Eybna's production of terpene formulations for optimizing the medical benefits of cannabis.
Analyzing the complex chemistry of the cannabis plant may help scientists to develop specific cannabis-based drugs for specific conditions.
Products containing either too little or too much CBD than labeled could negate potential clinical benefit to patients.
The Joint Venture will initially focus on building out an approximate 2,000 square foot facility at Abba’s Pickering cannabis grow facility, to house a cannabis oil extraction operation focused on producing the oils and extracts currently permitted under ACMPR.
Lack of regulations and inadequate testing leave products in question.
Whether you are a new lab starting up or a seasoned lab looking to upgrade your old equipment; there are many important aspects you need to think about before deciding to make your equipment purchase.